Publication: Ga-68-Tetraazacyclododecane Tetraacetic Acid-DPhe1-Tyr3-Octreotate Positron Emission Tomography/Computed Tomographic Findings of Large-Cell Neuroendocrine Carcinoma of the Lung in a Child
Loading...
Files
Date
2022-10-01
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Primary lung cancers in children are rare, and most children are diagnosed incidentally while being investigated for another medical problem. The diagnosis of primary lung tumors in children is very difficult because many children are asymptomatic until the advanced stages of the disease and nonspecific imaging findings. Although the usage of 68Ga-tetraazacyclododecane tetraacetic acid-DPhe1-Tyr3-octreotate (68Ga-DOTATATE) positron emission tomography/computed tomography (PET/CT) in adult patients is well known, it is a relatively new imaging modality for the pediatric patient group. Herein, we presented a unique case of large-cell neuroendocrine carcinoma of the lung in a child on 68Ga-DOTATATE PET/CT.
Description
Keywords
Tıp, Dahili Tıp Bilimleri, Nükleer Tıp, Sağlık Bilimleri, Medicine, Internal Medicine Sciences, Nuclear medicine, Health Sciences, RADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME, Klinik Tıp, Klinik Tıp (MED), RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING, CLINICAL MEDICINE, Clinical Medicine (MED), Radyoloji ve Ultrason Teknolojisi, Radyoloji, Nükleer Tıp ve Görüntüleme, Radiological and Ultrasound Technology, Radiology, Nuclear Medicine and Imaging, Child, large-cell neuroendocrine carcinoma, positron emission tomography, computed tomography, tetraazacyclododecane tetraacetic acid-DPhe1-Tyr3-octreotate, TUMORS, Child, large-cell neuroendocrine carcinoma, positron emission tomography/computed tomography, tetraazacyclododecane tetraacetic acid-DPhe1-Tyr3-octreotate
Citation
Filizoglu N., Kesim S., ÖZGÜVEN S., "Ga-68-Tetraazacyclododecane Tetraacetic Acid-DPhe1-Tyr3-Octreotate Positron Emission Tomography/Computed Tomographic Findings of Large-Cell Neuroendocrine Carcinoma of the Lung in a Child", INDIAN JOURNAL OF NUCLEAR MEDICINE, cilt.37, sa.4, ss.396-397, 2022